Exact Sciences Corp (EXAS) Misses Q1 Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
Total Operating expenses: 54.23M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Exact Sciences Corp (NASDAQ: EXAS) reported Q1 EPS of ($0.23), $0.04 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $294 thousand versus the consensus estimate of $600 thousand.
For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Can broadening earnings growth sustain the equity upcycle? JPM weighs in
- Shopify gains as Cantor Fitzgerald hikes price target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
